Bladder cancer is when a tumor grows in your bladder, a pouch-like organ that stores your urine. (Photo Credit: SEBASTIAN KAULITZKI/Science Source) The American Cancer Society’s estimates for ...

The fourth layer is fatty connective tissue. It separates the bladder from other body organs, such as the prostate and kidneys. Doctors describe your bladder cancer based on how far it has spread ...

FDA approved Imfinzi with gemcitabine and cisplatin for muscle-invasive bladder cancer, based on NIAGARA trial results showing improved survival outcomes. The regimen integrates immunotherapy in pre- ...

When it comes to genitourinary cancers in men, most people put their attention toward prostate cancer or testicular cancer. What many people fail to realize is that another form—bladder cancer—is the ...

As you process your diagnosis, moving forward with treatment is crucial to optimizing your health and recovery. A person's precise bladder cancer treatment plan will depend on a number of factors, ...

Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial. Previous data showed that in the phase 3 JAVELIN ...

Johnson & Johnson's confidence in its bladder cancer therapy TAR-200 – dented by a negative phase 3 readout last year – seems to be justified. New data from the SunRISe-1 study of TAR-200 in ...

Cystectomy often treats bladder cancer. But bladder removal surgery can help other bladder problems, too. After cystectomy, your urine may need a new route to exit your body (urinary diversion).

Results from the Phase IIb SunRISe-1 study demonstrated a one-year duration of response with the TAR-200 intravesical gemcitabine-releasing system in patients with Bacillus ...

high-risk non-muscle invasive bladder cancer "Patients with bladder cancer need more effective treatment options that are both tolerable and easily incorporated into everyday practice, especially ...

Oral presentation provides update from QUILT-3.032 on durable complete responses to ANKTIVA ® plus BCG in BCG-unresponsive non-muscle invasive bladder cancer carcinoma in situ (NMIBC CIS ...